FEROLLA, PIERO
 Distribuzione geografica
Continente #
NA - Nord America 1.225
EU - Europa 1.100
AS - Asia 264
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.597
Nazione #
US - Stati Uniti d'America 1.223
IE - Irlanda 299
UA - Ucraina 272
SE - Svezia 166
HK - Hong Kong 116
IT - Italia 106
VN - Vietnam 94
DE - Germania 66
FI - Finlandia 61
RU - Federazione Russa 44
CN - Cina 36
GB - Regno Unito 32
FR - Francia 24
TR - Turchia 11
BE - Belgio 7
CH - Svizzera 7
AT - Austria 6
UZ - Uzbekistan 4
BR - Brasile 3
CO - Colombia 3
RO - Romania 3
CZ - Repubblica Ceca 2
GR - Grecia 2
NL - Olanda 2
CA - Canada 1
EU - Europa 1
KH - Cambogia 1
LB - Libano 1
ME - Montenegro 1
MX - Messico 1
NZ - Nuova Zelanda 1
SG - Singapore 1
Totale 2.597
Città #
Chandler 304
Dublin 299
Jacksonville 156
San Mateo 123
Hong Kong 116
Dong Ket 94
Ann Arbor 57
Medford 53
Princeton 53
Andover 42
Wilmington 37
Beijing 31
Altamura 26
Perugia 26
Lawrence 18
Saint Petersburg 13
Izmir 11
Woodbridge 11
Norwalk 10
Redmond 10
Boardman 9
Helsinki 9
Auburn Hills 7
Brussels 7
Foligno 7
Des Moines 6
Ashburn 4
Falls Church 4
Shanghai 4
Florence 3
Lausanne 3
New York 3
Den Haag 2
Edinburgh 2
Iglesias 2
Los Angeles 2
Padova 2
Rockville 2
Salvador 2
San Paolo di Civitate 2
Sesto Fiorentino 2
Auckland 1
Avellino 1
Avigliano 1
Barletta 1
Bogotá 1
Bronx 1
Bucharest 1
Cento 1
Cochrane 1
Falkenstein 1
Formigine 1
Fuzhou 1
Glasgow 1
Grumo Appula 1
Islington 1
Itapipoca 1
Ludwigshafen 1
Medellín 1
Mexico City 1
Moscow 1
Odesa 1
Osimo 1
Palestrina 1
Pereira 1
Philadelphia 1
Phnom Penh 1
Podgorica 1
Pomezia 1
Prague 1
Reghin 1
Rome 1
San Severo 1
Stockholm 1
Timisoara 1
Torino 1
Trieste 1
Verona 1
Totale 1.611
Nome #
(111)In-pentetreotide SPET/CT in carcinoid tumours: is the role of hybrid systems advantageous in abdominal or thoracic lesions? 103
Effect of EPA on Neonatal Pig Sertoli Cells “In Vitro”: A Possible Treatment to Help Maintain Fertility in Pre-Pubertal Boys Undergoing Treatment With Gonado-Toxic Therapies 103
Aspetti clinici dei tumori neuroendocrini 85
Tumori neuroendocrini toracici ben differenziati: la corretta gestione clinica 81
Typical Carcinoids of the Lung: Multicentric Forms, Lymph-node Metastases and Long-term Survival in 83 Patients 80
Tumori Neuroendocrini del Polmone, aspetti medici 78
Epidemiology of non-gastroenteropancreatic (neuro)endocrine tumours 75
La caratterizzazione biologica dei NET: ruolo diagnostico e prognostico dei marcatori neuroendocrini 74
Prevalenza del fenotipo neuroendocrino nelle neoplasie del timo 64
Analoghi della somatostatina nei tumori neuroendocrini gastro-entero-pancreatici e toracici 63
Neuroendocrine Features Of Well Differentiated Human Neuroendocrine Lung Tumors - Atti XXII Congresso Nazionale Società Italiana Endocrino Chirurgia 61
Well differentiated thoracic neuroendocrine tumors: clinical management and therapy 61
Prevalence of the neuroendocrine phenotype in thymus neoplasms. 61
Typical Carcinoid of the lung: multicentric forms, lymph-node metastases and long-term survival in 83 patients. 70th Annual International Scientific Assembly of the American College of Chest Physicians (ACCP) 60
Endoscopia virtuale e tecniche di ricostruzione tridimensionali con TC nella diagnosi e nel follow-up delle lesioni tracheobronchiali - 105° Congresso Società Italiana di Chirurgia 59
Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids 59
Analoghi della somatostatina nei tumori neuroendocrini gastro-entero-pancreatici e toracici 56
Long-term survival and prognostic factors in neuroendocrine tumors: Results from a large multicenter study 53
18F-deoxy-D-glucose positron emission tomography (FDG_PET) increases the detection rate of recurrent or residual medullary thyroid cancer 51
La fisiopatologia del timo 51
Evaluation of accuracy of circulating CgA and NSE in the pre- and post-operative phase in bronchial carcinoids 50
Health related quality of life, anxiety and depression among patients with carcinoid tumors 49
Efficacy and safety of high dose OCTREOTIDE LAR treatment in patients with progressive well differentiated neuroendocrine tumors 48
Shortened interval of octreotide LAR administration is effective in patients with well differentiated neuroendocrine carcinomas in progression on standard doses. 48
Neuroendocrine markers and clinical aoutcome in 100 well differentiated (carcinoid) and 52 poorly differentiated lung neuroendocrine tymours. XXX Congresso Nazionale Societa' Italiana Endocrinologia 47
Follow up e complicanze del trattamento medico della patologia surrenalica 47
Neuroendocrine features of well differentiated human neuroendocrine lung tumors - 6th European Congress of Endocrinology 46
Surgical treatment of well differentiated neuroendocrine tumours of the lung 46
Surgical treatment of neuroendocrine tumors of the lung 45
EFFICACY AND SAFETY OF HIGH DOSES OF LONG-ACTING SOMATOSTATIN ANALOGUES FOR TREATMENT OF WELL DIFFERENTIATED FUNCTIONING NEUROENDOCRINE TUMORS 44
“Preliminary study of tumor size response to low and high doses cabergolina therapy in clinically non-functioning macroadenomas with different D2 receptor expression detected with 123-I-IBZM pituitary scintigraphy” 43
FDG-PET, I Metaiodobenylguanidine and 111 in DPTA-Octreotide: scintigraphy for detection of recurrent / residual medullary thyroid cancer 42
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses. 42
Comorbilità di ansia e depressione nei pazienti con tumori carcinoidi - Comorbility between anxiety and depression in patients with carcinoid tumors - 42
GH-deficit in the developing age: critical analysis of the diagnostic tests 41
Surgical treatment of neuroendocrine tumors of the lung. 2nd EACTS/ESTS Joint Meeting. 40
In vitro” and “in vivo” somatostatin receptor subtype expression in well differentiated lung neuroendocrine tumors ( typical anc atypical brochial carcinoid) 40
The biological characterization of neuroendocrine tumors: the role of neuroendocrine markers. 38
macro-prolactinomas:which the therapeutic space of dopamine-agonists? 37
Neuroendocrine prevalence in Thymic Tumors 37
Efficacy and safety of high doses of long-acting somatostain analogues for treatment of well differentiated secreting neuroendocrine tumors 34
LA TERAPIA DEI PROLATTINOMI IN TEMPO DI SPENDING REVIEW. BROMOCRIPTINA vs CABERGOLINA: ANALISI COSTO-EFFICACIA 34
Evaluation of the different role of 111 In -pentetreotide SPECT/CT of thorax and abdomen in investigating carcinoid tumours 34
Neuroendocrine Markers And Clinical Outcome In 100 Well Differentiated (Carcinoids) And 52 Poorly Differentiated Lung Neuroendocrine Tumours; 34
Lack of Accuracy of Circulating Chromogranin A in the Preoperative Diagnosis of Lung Neuroendocrine Tumors 33
Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice 33
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer. 31
Papillary thyroid carcinoma in a MEN 1 patient.” 31
Prognostic Significance of Pulmonary Multifocal Neuroendocrine Proliferation With Typical Carcinoid 30
CD 44 expression as a major prognostic factor in lung neuroendocrine tumors 30
Deficit di GH nell’età evolutiva : analisi critica dei test diagnostici 30
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study 29
Postsurgical follow-up is always necessary in bronchial carcinoid 23
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian Epidemiological study: THE NET MANAGEMENT STUDY 21
Totale 2.677
Categoria #
all - tutte 8.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201920 0 0 0 0 0 0 0 0 0 5 15 0
2019/2020249 10 3 38 3 41 8 42 3 41 21 16 23
2020/2021552 4 40 21 40 143 28 42 3 59 17 53 102
2021/2022500 9 86 11 30 10 4 3 152 82 5 50 58
2022/2023878 57 118 16 65 77 85 2 43 371 1 30 13
2023/2024221 20 29 27 4 3 3 70 7 48 10 0 0
Totale 2.677